Hojgaard, M., Zhang, J., Sohn, J., Doger, B., González-Martín, A., Falchook, G. S., Cruz-Merino, L. D. L., Teng, C., Arcilla, J. B., Freyer, G., Sanchez, V., Ouali, K., Xu, W., Xu, Y., Kolur, A., Zhang, Y., Zhang, Y., Chen, V., Yarza, R. (2026). EIK1003, a PARP1-selective inhibitor, in combination with paclitaxel (PTX): Initial combination and updated monotherapy results from a phase 1/2 study EIK1003-001 in advanced solid tumors.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.3102